+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Venous Disease Interventional Therapy Market - Global Forecast 2026-2032- Product Image
Venous Disease Interventional Therapy Market - Global Forecast 2026-2032- Product Image
New

Venous Disease Interventional Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118697
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Venous Disease Interventional Therapy Market is undergoing transformation, with evolving clinical practices, advancing technologies, and regulatory shifts all impacting treatment delivery and stakeholder decision-making. Leaders seeking growth and operational resilience will benefit from a comprehensive understanding of segmentation, competitive dynamics, and global adoption patterns within this high-impact sector.

Market Snapshot: Venous Disease Interventional Therapy Market

The Venous Disease Interventional Therapy Market grew from USD 1.39 billion in 2025 to USD 1.51 billion in 2026. It is expected to continue growing at a CAGR of 9.84%, reaching USD 2.68 billion by 2032. This sustained expansion is driven by increased adoption of minimally invasive interventions, continuous advancements in device technologies, and the migration of procedures to ambulatory and clinic-based care settings. Demand is further reinforced by an emphasis on quality outcomes, cost efficiencies, and growing global access to advanced vascular care modalities.

Scope & Segmentation

  • Therapy Types: Catheter Directed Thrombolysis, Endovenous Laser Ablation (incorporating Bare Fiber, Radial Fiber, Side Firing Fiber variants), Mechanochemical Ablation, Radiofrequency Ablation (Bipolar and Monopolar Catheters), Sclerotherapy (Foam and Liquid Sclerosants), Ultrasound Guided Foam Sclerotherapy, and Venous Stenting.
  • Product Types: Foam Sclerotherapy Kits, Laser Fiber, Mechanical Thrombectomy Devices, Radiofrequency Catheter, Sclerosants (Foam and Liquid), Stents (Balloon Expanding and Self Expanding), and Ultrasound Systems.
  • Applications: Chronic Venous Insufficiency, Deep Vein Thrombosis, Pulmonary Embolism, Varicose Veins, and Venous Ulcers.
  • End User Settings: Ambulatory Surgical Centers, Clinics (Outpatient Clinics and Vein Clinics), and Hospitals (Public and Private Hospitals).
  • Distribution Channels: Direct Sales, Distributors, and Online platforms.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Minimally invasive therapies are now standard for a broad spectrum of venous conditions, enabling outpatient care and influencing procurement cycles.
  • Product bundling and integrated solutions are gaining traction, as providers seek to streamline workflows and improve cost predictability in high-volume settings.
  • Provider strategies are increasingly shaped by the need for robust clinical evidence, comparative effectiveness data, and reliable outcomes to satisfy payer requirements.
  • Differentiated device design—such as enhancements in fiber technologies, imaging, and modular system architectures—supports tailored therapies aligned with patient-specific needs.
  • Collaborative initiatives between device manufacturers, distributors, and care teams promote value-based adoption and drive operational efficiencies across diverse healthcare environments.
  • Global regulatory and reimbursement variations require tailored commercialization strategies and adaptive market entry planning in each region.

Tariff Impact: Navigating Supply Chain and Procurement Complexity

Recent tariff measures in the United States create strategic challenges for sourcing key components in venous therapy devices. Adjustments to landed costs, especially for internationally sourced precision catheter parts and specialty materials, may prompt manufacturers to accelerate nearshoring and diversify supplier portfolios. These shifts can affect product timelines, inventory management, and overall supply continuity. Health systems and ambulatory centers should evaluate procurement agreements for long-term resilience, considering supply reliability and flexible contract structures to manage potential volatility. Organizations that proactively adapt their sourcing and procurement strategies are better positioned to maintain continuous access and fiscal stability.

Methodology & Data Sources

Primary research combined structured interviews with vascular surgeons, interventional radiologists, and supply chain leaders to capture clinical and operational perspectives. Advisory panels provided context on regional dynamics, training requirements, and evolving clinical endpoints. Secondary sources included peer-reviewed literature, regulatory documentation, and detailed device registries. Data integrity was maintained through cross-referencing and iterative expert validation, ensuring reliable, reproducible findings underpin the analysis.

Why This Report Matters

  • Delivers actionable segmentation and technology insights to support product development, procurement planning, and commercial execution across key provider settings.
  • Guides strategic investment and supply chain optimization for manufacturers and distributors facing evolving regulatory, tariff, and demand environments.
  • Supports providers and decision-makers with robust analysis of shifting adoption dynamics, reimbursement expectations, and global market access trends.

Conclusion

Technological advancement, clinical evidence demands, and adaptive supply strategies are collectively redefining competitive positioning in venous interventional therapy. By leveraging targeted insights and operational resilience, stakeholders can align offerings with market needs, drive successful adoption, and deliver improved patient care outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of ultrasound-guided mechanochemical ablation techniques in chronic venous insufficiency treatment
5.2. Emerging role of bioresorbable stent technologies in deep vein thrombosis management
5.3. Integration of AI-driven image analytics for precision targeting in venous interventions
5.4. Expansion of outpatient ambulatory surgery centers offering minimally invasive vein therapies
5.5. Increasing use of cyanoacrylate adhesive systems as nonthermal sclerotherapy alternatives
5.6. Rise of drug-coated balloon catheters for acute and post-thrombotic deep vein occlusions
5.7. Regulatory approvals fueling growth of novel nonthermal ablation devices in Europe and Asia
5.8. Surge in telehealth-based postoperative monitoring to reduce complications and readmissions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Venous Disease Interventional Therapy Market, by Therapy Type
8.1. Introduction
8.2. Catheter Directed Thrombolysis
8.3. Endovenous Laser Ablation
8.3.1. Bare Fiber
8.3.2. Radial Fiber
8.3.3. Side Firing Fiber
8.4. Mechanochemical Ablation
8.5. Radiofrequency Ablation
8.5.1. Bipolar Catheter
8.5.2. Monopolar Catheter
8.6. Sclerotherapy
8.6.1. Foam Sclerosants
8.6.2. Liquid Sclerosants
8.7. Ultrasound Guided Foam Sclerotherapy
8.8. Venous Stenting
9. Venous Disease Interventional Therapy Market, by Product Type
9.1. Introduction
9.2. Foam Sclerotherapy Kits
9.3. Laser Fiber
9.4. Mechanical Thrombectomy Devices
9.5. Radiofrequency Catheter
9.6. Sclerosants
9.6.1. Foam Sclerosants
9.6.2. Liquid Sclerosants
9.7. Stents
9.7.1. Balloon Expanding
9.7.2. Self Expanding
9.8. Ultrasound Systems
10. Venous Disease Interventional Therapy Market, by Application
10.1. Introduction
10.2. Chronic Venous Insufficiency
10.3. Deep Vein Thrombosis
10.4. Pulmonary Embolism
10.5. Varicose Veins
10.6. Venous Ulcers
11. Venous Disease Interventional Therapy Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.3.1. Outpatient Clinics
11.3.2. Vein Clinics
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Venous Disease Interventional Therapy Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Americas Venous Disease Interventional Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Venous Disease Interventional Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Venous Disease Interventional Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Boston Scientific Corporation
16.3.2. Abbott Laboratories
16.3.3. Medtronic plc
16.3.4. Johnson & Johnson
16.3.5. Becton, Dickinson and Company
16.3.6. Terumo Corporation
16.3.7. Teleflex Incorporated
16.3.8. AngioDynamics, Inc.
16.3.9. Merit Medical Systems, Inc.
16.3.10. Penumbra, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET: RESEARCHAI
FIGURE 26. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 27. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET: RESEARCHCONTACTS
FIGURE 28. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CATHETER DIRECTED THROMBOLYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CATHETER DIRECTED THROMBOLYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY BARE FIBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY BARE FIBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIAL FIBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIAL FIBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SIDE FIRING FIBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SIDE FIRING FIBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY MECHANOCHEMICAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY MECHANOCHEMICAL ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY BIPOLAR CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY BIPOLAR CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY MONOPOLAR CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY MONOPOLAR CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY FOAM SCLEROSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY FOAM SCLEROSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY LIQUID SCLEROSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY LIQUID SCLEROSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ULTRASOUND GUIDED FOAM SCLEROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ULTRASOUND GUIDED FOAM SCLEROTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VENOUS STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VENOUS STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY FOAM SCLEROTHERAPY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY FOAM SCLEROTHERAPY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY LASER FIBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY LASER FIBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY MECHANICAL THROMBECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY MECHANICAL THROMBECTOMY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY FOAM SCLEROSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY FOAM SCLEROSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY LIQUID SCLEROSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY LIQUID SCLEROSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY BALLOON EXPANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY BALLOON EXPANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VEIN CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY VEIN CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 168. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 169. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 172. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 173. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 176. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 177. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 178. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 179. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 184. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 185. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. CANADA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 192. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 193. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 195. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. MEXICO VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY ENDOVENOUS LASER ABLATION, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROTHERAPY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY SCLEROSANTS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA VENOUS DISEASE INTERVENTIONAL THERAPY MARKET SIZE, BY CLINICS, 2025-2030 (USD M

Companies Mentioned

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Spectranetics Corporation
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.51 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.68 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiovascular Intervention: A Companion to Braunwald's Heart Disease - Product Image

Cardiovascular Intervention: A Companion to Braunwald's Heart Disease

  • Book
Cardiovascular Intervention. A Companion to Braunwald's Heart Disease. Edition No. 2 - Product Image

Cardiovascular Intervention. A Companion to Braunwald's Heart Disease. Edition No. 2

  • Book
Vascular Malformations Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Vascular Malformations Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Cardiovascular Thrombus. From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions - Product Image

Cardiovascular Thrombus. From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions

  • Book
Peripheral Coil Embolization System Market - Global Forecast 2026-2032 - Product Image

Peripheral Coil Embolization System Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.